Iveta Merćep

6PUBLICATIONS
17CO-AUTHORS
Cardiology (incl. cardiovascular diseases)PharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical Practice.

|Jun 26, 2025
Reshaping Dyslipidaemia Treatment with Bempedoic Acid-A Narrative Review.

Dominik Strikic, Zvonimir Begic, Ivana Radman

|Sep 28, 2023
Present and Future of Dyslipidaemia Treatment-A Review.

Iveta Merćep, Andro Vujević, Dominik Strikić

|Jul 27, 2022
New Therapeutic Approaches in Treatment of Dyslipidaemia-A Narrative Review.

Iveta Merćep, Dominik Strikić, Ana Marija Slišković

|Mar 03, 2022
Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9-A Narrative Review.

Iveta Merćep, Nikolina Friščić, Dominik Strikić

|Oct 20, 2021
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.

Iveta Merćep, Ivana Radman, Vladimir Trkulja

Pageof 1

Frequent Collaborators

4 joint publications

Dominik Strikić

3 joint publications

Ana Marija Slišković

2 joint publications

Vladimir Trkulja

2 joint publications

Tamara Božina